Tae-Yoon Kim Selected Research

Superoxide Dismutase

3/2022	Inhibitory effects of superoxide dismutase 3 on IgE production in B cells.
1/2022	Superoxide dismutase 3 prevents early stage diabetic retinopathy in streptozotocin-induced diabetic rat model.
6/2021	Superoxide Dismutase 3-Transduced Mesenchymal Stem Cells Preserve Epithelial Tight Junction Barrier in Murine Colitis and Attenuate Inflammatory Damage in Epithelial Organoids.
1/2020	Superoxide Dismutase 3 Inhibits LL-37/KLK-5-Mediated Skin Inflammation through Modulation of EGFR and Associated Inflammatory Cascades.
12/2018	Enhanced therapeutic effects of human mesenchymal stem cells transduced with superoxide dismutase 3 in a murine atopic dermatitis-like skin inflammation model.
10/2018	Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
8/2018	Author Correction: Inhibitory effects of superoxide dismutase 3 on Propionibacterium acnes-induced skin inflammation.
1/2018	Inhibitory effects of superoxide dismutase 3 on Propionibacterium acnes-induced skin inflammation.
1/2017	Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis.
2/2016	Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae-Yoon Kim Research Topics

Disease

26	Inflammation (Inflammations) 03/2022 - 09/2006
20	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017 - 03/2003
13	Neoplasms (Cancer) 01/2018 - 08/2002
12	Atopic Dermatitis (Atopic Eczema) 03/2022 - 01/2007
10	Skin Diseases (Skin Disease) 02/2021 - 01/2007
5	Asthma (Bronchial Asthma) 03/2022 - 04/2012
5	Melanoma (Melanoma, Malignant) 02/2021 - 10/2009
4	Hyperplasia 01/2017 - 09/2006
4	Hypoxia (Hypoxemia) 08/2015 - 10/2007
3	Erythema 02/2021 - 03/2006
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 03/2022 - 01/2017
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 08/2015
2	Wounds and Injuries (Trauma) 01/2020 - 09/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 10/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2015 - 03/2013
2	Pathologic Neovascularization 08/2015 - 01/2008
2	Carcinogenesis 10/2014 - 10/2009
2	Dermatitis 03/2014 - 07/2011
2	Ischemia 03/2013 - 08/2012
2	Atherosclerosis 08/2012 - 04/2012
2	Vascular Diseases (Vascular Disease) 08/2012 - 12/2011
2	Edema (Dropsy) 09/2010 - 09/2006
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2003 - 12/2002
1	Parasitic Diseases (Parasitic Disease) 03/2022
1	Diabetes Mellitus 01/2022
1	Candidiasis (Moniliasis) 12/2021
1	Constipation 08/2021
1	Colitis 06/2021
1	Skin Neoplasms (Skin Cancer) 02/2021
1	Hypersensitivity (Allergy) 02/2021
1	Tonsillar Neoplasms 01/2021
1	Bacteremia 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2018

Drug/Important Bio-Agent (IBA)

19	Superoxide DismutaseIBA 03/2022 - 09/2006
11	CytokinesIBA 06/2021 - 01/2007
8	Proteins (Proteins, Gene)FDA Link 06/2021 - 10/2003
6	Immunoglobulin E (IgE)IBA 03/2022 - 01/2007
6	ChemokinesIBA 03/2017 - 07/2007
5	OvalbuminIBA 03/2022 - 11/2012
4	Biological ProductsIBA 01/2018 - 11/2003
4	Imiquimod (Aldara)FDA LinkGeneric 10/2017 - 02/2016
4	AntioxidantsIBA 03/2016 - 12/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015 - 08/2002
4	EnzymesIBA 02/2015 - 12/2011
3	Mitogen-Activated Protein KinasesIBA 06/2021 - 01/2017
3	Leucine (L-Leucine)FDA Link 01/2020 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 04/2003
3	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2010
3	NF-kappa B (NF-kB)IBA 02/2016 - 04/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2016 - 09/2010
3	capsiateIBA 08/2015 - 01/2008
3	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 03/2003
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 08/2015
2	Retinaldehyde (Retinal)IBA 01/2022 - 08/2015
2	alpha-MSHIBA 02/2021 - 10/2009
2	CPG-oligonucleotideIBA 02/2021 - 07/2007
2	OligodeoxyribonucleotidesIBA 02/2021 - 12/2002
2	Interleukin-4 (Interleukin 4)IBA 02/2021 - 11/2007
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020 - 10/2015
2	Arginine (L-Arginine)FDA Link 01/2020 - 10/2015
2	Amino Acids FDA Link 01/2020 - 10/2015
2	Interleukin-23 (Interleukin 23)IBA 03/2017 - 04/2013
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2017
2	rhododendrinIBA 01/2017 - 08/2013
2	Janus KinasesIBA 02/2016 - 07/2015
2	Oxygen (Dioxygen)IBA 08/2015 - 12/2011
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2015 - 07/2015
2	InterleukinsIBA 03/2014 - 10/2003
2	Transcription Factors (Transcription Factor)IBA 05/2012 - 10/2007
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2011 - 09/2006
2	Interleukin-10 (Interleukin 10)IBA 12/2011 - 11/2007
2	Melanins (Melanin)IBA 08/2011 - 10/2009
2	src-Family KinasesIBA 05/2010 - 04/2004
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2007 - 04/2004
1	secukinumabIBA 12/2021
1	Irritants (Vesicants)IBA 08/2021
1	Dietary Fiber FDA Link 08/2021
1	PrebioticsIBA 08/2021
1	Dextran SulfateIBA 06/2021
1	Cadherins (E-Cadherin)IBA 06/2021
1	Melanocyte-Stimulating Hormones (MSH)IBA 02/2021
1	ArgonIBA 02/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	PyrinIBA 01/2020
1	PAR-2 ReceptorIBA 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	NucleotidesIBA 01/2020
1	Therapeutic UsesIBA 12/2018
1	Protein Kinases (Protein Kinase)IBA 10/2018
1	Adenosine Monophosphate (AMP)IBA 10/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2018
1	Peptidoglycan (Murein)IBA 01/2018
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2018

Therapy/Procedure

8	Therapeutics 01/2020 - 10/2003
3	Subcutaneous Injections 01/2020 - 09/2011
2	Immunotherapy 12/2012 - 12/2002
2	Radiotherapy 12/2012 - 03/2006
2	Drug Therapy (Chemotherapy) 12/2012 - 11/2003
1	Critical Care (Surgical Intensive Care) 01/2020
1	Length of Stay 01/2020